News Feed - US
May 15, 2024 16:05 ET
GSE Systems Reports First Quarter 2024 Financial Results
Conference Call Scheduled for today, May 15, 2024 at 4:30pm ET
May 15, 2024 16:05 ET
Hawkins, Inc. Declares Quarterly Cash Dividend of $0.16 Per Share
The Board of Directors of Hawkins, Inc. (Nasdaq: HWKN), at its meeting on May 15, 2024, declared a quarterly cash dividend of $0.16 per share payable June 14, 2024, to shareholders of record at the close of business on May 31, 2024. Hawkins has...
May 15, 2024 16:05 ET
HireQuest, Inc. Declares Quarterly Dividend
GOOSE CREEK, SC / ACCESSWIRE / May 15, 2024 / HireQuest, Inc. (Nasdaq:HQI), a national franchisor of direct dispatch, executive search, and commercial staffing services, today announced that its Board of Directors has declared a quarterly dividend of $0.06 per share. The dividend is payable June 17, 2024, to shareholders of record at the close of business on June 3, 2024.
May 15, 2024 16:05 ET
Illumina To Webcast Upcoming Investor Conference
SAN DIEGO, May 15, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:
May 15, 2024 16:05 ET
Inotiv Reports Second Quarter Financial Results for Fiscal 2024 and Provides Business Update
Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced...
May 15, 2024 16:05 ET
Lam Research Corporation Announces Participation at Upcoming Conferences
FREMONT, Calif., May 15, 2024 /PRNewswire/ -- Lam Research Corp. (Nasdaq: LRCX) today announced that Tim Archer, President and Chief Executive Officer and Doug Bettinger, Executive Vice President and Chief Financial Officer, will participate in the following upcoming investor events:
May 15, 2024 16:05 ET
Leslie’s, Inc. Appoints Maile (Clark) Naylor to Board of Directors
Leslie's, Inc. ("Leslie's" or the “Company”; NASDAQ: LESL), the largest and most trusted direct-to-consumer brand in the U.S. pool and spa care industry, announced that the Company has appointed Maile (Clark) Naylor to its Board of Directors,...
May 15, 2024 16:05 ET
Leslie’s, Inc. Appoints Maile (Clark) Naylor to Board of Directors
Leslie's, Inc. ("Leslie's" or the “Company”; NASDAQ: LESL), the largest and most trusted direct-to-consumer brand in the U.S. pool and spa care industry, announced that the Company has appointed Maile (Clark) Naylor to its Board of Directors,...
May 15, 2024 16:05 ET
Leslie’s, Inc. Appoints Maile (Clark) Naylor to Board of Directors
Leslie's, Inc. ("Leslie's" or the “Company”; NASDAQ: LESL), the largest and most trusted direct-to-consumer brand in the U.S. pool and spa care industry, announced that the Company has appointed Maile (Clark) Naylor to its Board of Directors,...
May 15, 2024 16:05 ET
Merit Medical Executive Leadership Team Update
Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced the appointment of Joe Wright as President, effective immediately. As President, Mr. Wright will be responsible for the oversight of Merit’s...
May 15, 2024 16:05 ET
Mingteng International Corporation Inc. Announces Financial Results for Fiscal Year 2023
WUXI, China, May 15, 2024 /PRNewswire/ -- Mingteng International Corporation Inc. (Nasdaq: MTEN) (the "Company" or "Mingteng International"), an automotive mold developer and supplier in China, today announced its financial results for the fiscal year ended December 31, 2023.
May 15, 2024 16:05 ET
Mobile Infrastructure Corporation Names New Chief Financial Officer
Mobile Infrastructure Corporation (NYSE American: BEEP) (“Mobile,” “Mobile Infrastructure,” or the “Company”), one of the largest institutional-quality, mobility-focused parking asset owners in the U.S. today announced the appointment of Paul Gohr as Chief Financial Officer (“CFO”), effective May 16, 2024. Mr. Gohr takes on the CFO responsibility from Stephanie Hogue, who will remain in her role as President and a member of the Board of Directors.
May 15, 2024 16:05 ET
Movano Health Reports Q1 2024 Financial Results and Provides Business Update
Submits exemplary Sp02 clinical trial results as part of FDA 510(k) clearance processPlans launch of Evie Med and focuses on B2B opportunitiesPlans arterial blood pressure study for JuneConference Call at 2:00 PM PT/ 5:00 PM ET Today
May 15, 2024 16:05 ET
Oncocyte Reports First Quarter 2024 Financial Results
Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today reported financial results for the quarter ended March 31, 2024. Recent Highlights Announced global commercialization partnership with Bio-Rad Laboratories, Inc.On track...
May 15, 2024 16:05 ET
OrthoPediatrics Corp. Continued Leading Sponsorship at 2024 EPOSNA Annual Meeting
OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its continued support of the combined 2024 Pediatric Orthopaedic Society of North America...
May 15, 2024 16:05 ET
PainReform Provides Business Update for the First Quarter of 2024
PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today provided a business update for the first quarter ended March 31, 2024....
May 15, 2024 16:05 ET
Red Robin Gourmet Burgers, Inc. to Release Fiscal First Quarter 2024 Results on May 29, 2024
ENGLEWOOD, Colo., May 15, 2024 /PRNewswire/ -- Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) ("Red Robin" or the "Company"), a full-service restaurant chain serving an innovative selection of high-quality gourmet burgers in a family-friendly atmosphere, today announced it will release financial results for its fiscal first quarter 2024 on Wednesday, May 29, 2024, after the market close, followed by a conference call to discuss these results at 4:30 p.m. ET.
May 15, 2024 16:05 ET
Rekor Systems, Inc. Reports First Quarter 2024 Financial Results
David Desharnais, President and COO, appointed as CEO; Viraj Mehta, Chief Investment Officer at Arctis Global, named Executive Director of the Board; Company Founder Robert A. Berman continues as Chairman.
May 15, 2024 16:05 ET
ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update
ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today reported financial results for the first quarter ended March 31, 2024 and provided a corporate strategic update. First...
May 15, 2024 16:05 ET
Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today reported financial results and provided a...
May 15, 2024 16:05 ET
Schwazze Announces First Quarter 2024 Financial Results
Schwazze Management to Host Conference Call Today at 5:00 p.m. Eastern Time
May 15, 2024 16:05 ET
Schwazze Announces First Quarter 2024 Financial Results
Schwazze Management to Host Conference Call Today at 5:00 p.m. Eastern Time
May 15, 2024 16:05 ET
Snail, Inc. Reports First Quarter 2024 Financial Results
CULVER CITY, Calif., May 15, 2024 /PRNewswire/ -- Snail, Inc. (NASDAQ: SNAL) ("Snail" or "the Company"), a leading, global independent developer and publisher of interactive digital entertainment, today announced financial results for its first quarter ended March 31, 2024.
May 15, 2024 16:05 ET
SOS Limited Reports 2023 Financial Results
Operating loss of $4.8 million compared to $215 million in 2022Revenues declined from $260.0 million to $92.4 million driven by a decline in commodity revenues due to slowdown in China economic activity.Crypto-Mining revenue up over 50XCash and cash equivalents of approximately $280 millionNEW YORK, May 15, 2024 /PRNewswire/ -- SOS Limited ("SOS" or the "Company") (NYSE: SOS) today reported its full year financial results for the twelve-months ended December 31, 2023.
May 15, 2024 16:05 ET
STRATA Skin Sciences Reports First Quarter 2024 Financial Results and Provides a Corporate Update
STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its financial...
May 15, 2024 16:05 ET
SWK Holdings Corporation Announces Financial Results for First Quarter 2024
Conference Call and Live Audio Webcast Scheduled for Thursday, May 16, 2024, at 10:00 a.m. ET
May 15, 2024 16:05 ET
Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors
WALTHAM, Mass., May 15, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced the appointment of Aleksandra Rizo, M.D., Ph.D., to its Board of Directors. Dr. Rizo has extensive clinical development experience and a track record of successfully leading the development of several hematology drugs from discovery through commercialization. She will serve as a member of the Science and Technology Committee of the Board. Dr. Rizo will replace Dr. Briggs Morrison who will step dow
May 15, 2024 16:05 ET
TILT Holdings Reports First Quarter 2024 Results
TILT Holdings Inc. (“TILT" or the “Company”) (Cboe: TILT) (OTCQB: TLLTF), a global provider of cannabis business solutions including inhalation technologies, cultivation, manufacturing, processing, brand development and retail, is reporting its...
May 15, 2024 16:05 ET
TOMI Environmental Solutions, Inc. Reports First Quarter 2024 Financial Results
TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, today...
May 15, 2024 16:05 ET
Velo3D Announces First Quarter 2024 Financial Results
Velo3D, Inc. (NYSE: VLD), a leading additive manufacturing technology company for mission-critical metal part
May 15, 2024 16:05 ET
WidePoint WYY Reports First Quarter 2024 Financial Results
FAIRFAX, VA / ACCESSWIRE / May 15, 2024 / WidePoint Corporation (NYSE American:WYY), the innovative enterprise cyber security and mobile technology provider, reported results for the first quarter ended March 31, 2024.
May 15, 2024 16:05 ET
Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance
Expects Revenue for Full Year 2024 of $116 Million to $120 Million
May 15, 2024 16:04 ET
May 15, 2024 16:03 ET
DV LOSS ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages DoubleVerify Holdings, Inc. Investors to Inquire About Securities Class Action Investigation – DV
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of DoubleVerify Holdings, Inc. (NYSE: DV) resulting from allegations that DoubleVerify may have issued...
May 15, 2024 16:01 ET
Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription...
May 15, 2024 16:01 ET
Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription...
May 15, 2024 16:01 ET
Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced its financial results for the first quarter ended March 31, 2024, and provided an update on...
May 15, 2024 16:01 ET
Apogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis Trial of APG777, a Novel Subcutaneous Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Infl
Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and...
May 15, 2024 16:01 ET
Avinger Reports First Quarter 2024 Results
Advances New OCT-Guided Coronary Product Development
May 15, 2024 16:01 ET
B. Riley Financial Reports First Quarter 2024 Results; Declares Quarterly Dividend of $0.50 per share
LOS ANGELES, May 15, 2024 /PRNewswire/ -- B. Riley Financial, Inc. (NASDAQ: RILY) ("B. Riley" or the "Company"), a diversified financial services platform, today released financial results for the three-month period ended March 31, 2024.
May 15, 2024 16:01 ET
Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update
Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced financial results for the first quarter ended March 31, 2024 and other recent business developments. “We...
May 15, 2024 16:01 ET
Cidara Therapeutics Regains Compliance with Nasdaq Continued Listing Rules
Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious...
May 15, 2024 16:01 ET
CSX Executive Vice President and Chief Financial Officer to Address Wolfe Research Global Transportation & Industrials Conference
CSX Corp. (NASDAQ: CSX) Executive Vice President and Chief Financial Officer, Sean Pelkey, will address the 17th Annual Wolfe Research Global Transportation & Industrials Conference in New York on Wednesday, May 22, at 8:35 a.m. Eastern time. This...
May 15, 2024 16:01 ET
Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III Program and its Two FDA Approved Commercial Products, Mydcombi and Clobetasol
Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic company with two FDA-approved products and a late-stage asset in pediatric progressive myopia, today announced its financial and operating results for the first quarter ended March 31,...
May 15, 2024 16:01 ET
Five Below, Inc. Announces First Quarter Fiscal 2024 Earnings Release and Conference Call Date
Five Below, Inc. (NASDAQ: FIVE), the trend-right, high-quality, extreme-value retailer for tweens, teens and beyond, today announced that its financial results for the first quarter of fiscal 2024 will be released after market close on Wednesday,...
May 15, 2024 16:01 ET
IZEA Reports Q1 2024 Revenue of $7.0 million
IZEA Worldwide, Inc. (NASDAQ: IZEA), the premier provider of influencer marketing technology, data, and services for the Creator Economy, reported its financial and operational results for the first quarter ended March 31, 2024. Q1 2024...
May 15, 2024 16:01 ET
Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial and Corporate Activities
Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company with a mission to develop next-generation immunotherapies in oncology that address cancer immune resistance, announced today financial results for the three months ended March 31,...
May 15, 2024 16:01 ET
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results
PALO ALTO, Calif., May 15, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and financial results for the quarter ended March 31, 2024.
May 15, 2024 16:01 ET
Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Monte Rosa Therapeutics, Inc. (“Monte Rosa”) (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that it has commenced an underwritten public offering of its common...
May 15, 2024 16:01 ET
News Release Providers
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.